10-Q: Tennant Q3 Earnings Decline Amid Macro Headwinds, Legal Costs
Quarterly Report
Tennant Company reports a decline in net sales and net income for the third quarter and year-to-date 2025, impacted by macroeconomic challenges and increased legal expenses.
Summary
- Net sales for Q3 2025 decreased by 4.0% to $303.3 million, and by 4.8% to $911.9 million for the nine months ended September 30, 2025, compared to the prior year periods.
- Net income for Q3 2025 fell to $14.9 million from $20.8 million in Q3 2024, and for the nine months, it decreased to $48.2 million from $77.1 million.
- Diluted earnings per share (EPS) were $0.80 for Q3 2025, down from $1.09 in Q3 2024, and $2.57 for the nine months, down from $4.03.
- Gross profit margin improved by 30 basis points to 42.7% in Q3 2025 due to strong price realization, but decreased by 110 basis points to 42.1% for the nine months due to product mix, inflation, and lower productivity.
- Selling and administrative expenses increased by $3.9 million in Q3 2025 and $5.5 million for the nine months, driven by strategic investments and $5.3 million (Q3) / $5.7 million (YTD) in legal contingency costs related to an intellectual property dispute.
- The company recorded an incremental accrued expense and liability of $5.3 million in Q3 2025 related to an adverse jury verdict in the Oxygenator Water Techs lawsuit, bringing total damages and interest to approximately $20.2 million.
- Cash and cash equivalents remained stable at $99.4 million as of September 30, 2025, with $409.3 million of unused borrowing capacity on its revolving credit facility.
- Acquired Reinigungstechnik 4 You GmbH (R4Y) on September 1, 2025, for $3.6 million to expand its EMEA footprint.
- Completed the initial go-live phase of a new global ERP system in the APAC region during Q3 2025.
Sentiment
Score: 4
Explanation: The company's financial performance for both the quarter and year-to-date shows significant declines in sales, net income, and EPS. While there are strategic initiatives and some positive indicators like Q3 gross margin improvement and strong liquidity, the overall financial results are weak, and macroeconomic headwinds and increased legal liabilities present considerable challenges. The outlook suggests continued pressure on margins in the near term.
Positives
- Gross profit margin improved by 30 basis points in Q3 2025 to 42.7%, primarily due to strong price realization and tariff-related pricing adjustments.
- EMEA net sales increased by 5.5% in Q3 2025 and 2.8% for the nine months, largely driven by favorable foreign currency exchange and acquisition-related growth.
- Net cash used in investing activities decreased significantly to $18.3 million for the nine months ended September 30, 2025, compared to $69.1 million in the prior year, due to one-time cash outflows in 2024 for a major investment and acquisition.
- Maintained a strong liquidity position with $99.4 million in cash and cash equivalents and approximately $409.3 million of unused borrowing capacity on the revolving facility.
- Successfully completed the initial go-live phase of a new global ERP system in the APAC region, expected to enhance internal control.
- The Board of Directors authorized the repurchase of 2,000,000 shares of common stock on February 11, 2025, demonstrating confidence in the company's value.
- Average interest rate on outstanding borrowings decreased to 5.7% in Q3 2025 from 6.5% in Q3 2024, contributing to lower net interest expense.
- Effective tax rate for Q3 2025 decreased to 23.2% due to discrete tax benefits from additional research credits.
Negatives
- Consolidated net sales decreased by 4.0% in Q3 2025 and 4.8% for the nine months, primarily due to organic volume declines across geographies, especially North America.
- Net income declined by 28.4% in Q3 2025 and 37.5% for the nine months, reflecting lower sales and increased operating expenses.
- Diluted EPS decreased by 26.6% in Q3 2025 and 36.2% for the nine months.
- Operating income decreased by 27.1% in Q3 2025 and 32.0% for the nine months, with operating margin falling to 7.4% and 8.0% respectively.
- Selling and administrative expenses increased as a percentage of net sales, rising to 31.8% in Q3 2025 and 30.8% for the nine months, partly due to strategic investments and significant legal costs.
- The company incurred an incremental $5.3 million liability in Q3 2025 for enhanced damages and prejudgment interest in the Oxygenator Water Techs lawsuit, bringing the total to $20.2 million.
- Net foreign currency transaction resulted in a $1.0 million loss for the nine months ended September 30, 2025, compared to a $0.1 million gain in the prior year, primarily due to the strengthening Euro.
- Debt-to-capital ratio increased to 27.1% as of September 30, 2025, from 24.3% at December 31, 2024.
- Net cash used in financing activities was $36.0 million for the nine months, compared to $8.1 million provided in the prior year, driven by increased common stock repurchases and lower proceeds from stock options.
Risks
- Persistent geopolitical tensions, elevated interest rates, monetary policy changes, and foreign currency fluctuations create global economic uncertainty.
- Ability to comply with global laws and regulations.
- Customer pricing sensitivities and intense competition in the business.
- Fluctuations in the cost, quality, or availability of raw materials and purchased components.
- Ability to adjust pricing to respond to cost pressures.
- Unforeseen product liability claims or product quality issues.
- Ability to attract, retain, and develop key personnel and create effective succession planning strategies.
- Ability to effectively develop and manage strategic planning and growth processes and related operational plans.
- Ability to successfully upgrade and evolve information technology systems, including potential complications with the new Enterprise Resource Planning (ERP) system.
- Cybersecurity risks to information technology systems.
- Occurrence of a significant business interruption.
- Ability to maintain the health and safety of workers.
- Challenges in integrating acquisitions.
- Ability to develop and commercialize new innovative products and services.
- Risks related to business transformation and strategic initiatives.
- Impact of U.S. tariffs and retaliatory measures increasing input costs, disrupting supply chains, and affecting customer demand.
- Uneven economic recovery in China, market saturation, and intensifying pricing competition impacting product sales.
- Elevated interest rates and persistent inflationary pressures in Mexico leading to delayed capital expenditure decisions and a sustained preference for rental solutions.
- Softening economic growth combined with heightened competitive pressures in Europe tempering demand for products.
- Potential for the company's exposure to loss in the Oxygenator Water Techs lawsuit to change, despite the current ruling not impacting product sales or long-term business objectives.
Future Outlook
The company anticipates slower global growth and uncertain effects of higher tariffs will necessitate aggressive margin management. The core strategy involves market-based pricing actions and targeted supply chain initiatives (supplier negotiations, dual sourcing, logistics shifts) to mitigate cost inflation. While near-term results may show timing mismatches between price increases and cost-out initiatives, potentially pressuring margins, disciplined execution is expected to sustain profitability and drive long-term margin expansion. The company continues to invest in innovation to support long-term demand while maintaining disciplined spending.
Management Comments
- We are actively monitoring global macroeconomic environment, including geopolitical conflict, potential impact of global supply chain constraints on material inflation, and change in demand for our products.
- Our core strategy involves market-based pricing actions and targeted supply chain initiatives, including supplier negotiations, dual sourcing, and logistics shifts, which are critical to mitigating tariff-related cost inflation and other input cost pressures.
- While near-term results may reflect timing mismatches between the realization of price increases, tariff impacts, and cost-out initiatives, which could pressure margins, our disciplined execution across pricing and cost management remains essential to sustaining profitability and driving long-term margin expansion.
- We are adapting our product and service offerings to meet evolving customer needs, and continuing to invest in innovation to support long-term demand, while maintaining disciplined spending across the organization.
- The ruling in the Oxygenator Water Techs lawsuit does not impact our ability to sell products and is not expected to affect our long-term business objectives.
Industry Context
The industrial cleaning equipment industry is currently navigating a volatile global business environment characterized by persistent geopolitical tensions, elevated interest rates, and foreign currency fluctuations. Uneven economic recoveries in key markets like China (market saturation, pricing competition) and Mexico (delayed capital expenditures due to inflation) are impacting demand. Europe is also experiencing softening economic growth and heightened competitive pressures. Companies in this sector are focusing on cost control, operational improvements, diversifying sourcing, and strategic pricing actions to mitigate tariff impacts and inflationary pressures, while continuing to invest in innovation to maintain market position.
Comparison to Industry Standards
- NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Accounting Standard Adoption | Adopted ASU 2023-07, Improvements to Reportable Segment Disclosures, which amends existing segment reporting guidance to enhance disclosures about significant segment expenses and CODM's use of segment profit/loss measures. | 2024-12-31 | No impact on consolidated financial statements, but resulted in incremental disclosures within footnotes. |
| Internal Controls and IT Systems | Completed the initial go-live phase of a new global ERP system in the APAC region, modifying existing internal controls over financial reporting and implementing new controls. | Q3 2025 | Expected to enhance the internal control environment by automating manual processes and standardizing business and reporting practices, but management continues to evaluate and monitor effectiveness as other regions transition. |
| Share Repurchase Authorization | Board of Directors authorized the repurchase of 2,000,000 shares of common stock. | 2025-02-11 | Provides flexibility for capital allocation and potential return to shareholders; 1,931,840 shares remain authorized under the program. |
Legal Proceedings
- On November 25, 2024, the company received an adverse jury verdict in an intellectual property damages dispute with Oxygenator Water Technologies, Inc. (OWT), awarding compensatory damages of $9.8 million plus $4.7 million in prejudgment interest.
- On September 17, 2025, the Court issued a post-trial ruling enhancing damages by 30%, resulting in total damages and interest of approximately $20.2 million, including $9.8 million in compensatory damages, $2.9 million in enhanced damages, and $7.4 million in prejudgment interest.
- An incremental accrued expense and corresponding liability of $5.3 million was recorded in the third quarter of 2025 due to the enhanced damages.
- The company intends to vigorously defend its position and is assessing next steps in the proceedings; the ruling does not impact the company's ability to sell its products and is not expected to affect its long-term business objectives.
Stakeholder Impact
- Shareholders: Experienced a significant decline in diluted EPS for both the quarter and year-to-date, and increased share repurchases may provide some support but overall financial performance is negative.
- Employees: Impacted by global workforce realignment and restructuring actions, leading to severance-related costs.
- Customers: Facing potential price adjustments due to strategic pricing actions and tariff-related adjustments, but also benefiting from continued investment in innovative products and services.
- Suppliers: Subject to supplier negotiations and dual sourcing initiatives as part of supply chain optimization efforts.
- Creditors: The company remains in compliance with all financial covenants under its credit agreement, and has substantial unused borrowing capacity, indicating continued financial stability for debt holders.
Next Steps
- Continue aggressive margin management through market-based pricing actions and targeted supply chain initiatives.
- Monitor global macroeconomic environment, including geopolitical conflict, material inflation, and demand changes.
- Adapt product and service offerings to meet evolving customer needs.
- Continue investing in innovative products and technologies to support long-term demand.
- Maintain disciplined spending across the organization.
- Vigorously defend position and assess next steps in the Oxygenator Water Techs lawsuit.
- Evaluate the impact of ASU 2023-09 on financial disclosures.
- Evaluate the effect of ASU 2024-03 on consolidated financial statements and related disclosures.
- Continue implementation and monitoring of the new global ERP system across other regions.
Key Dates
| Date | Description |
|---|---|
| 2021-04-05 | Entered into the Amended and Restated Credit Agreement (2021 Credit Agreement). |
| 2022-11-10 | Amended the 2021 Credit Agreement to replace LIBOR with Term SOFR as the reference rate for interest calculation. |
| 2022-12-01 | Interest rate swaps became effective to manage floating rate debt exposure. |
| 2023-11-01 | FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures. |
| 2023-12-01 | FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures. |
| 2024-02-21 | Acquired certain investment securities in Brain Corp, a privately held autonomous technology company. |
| 2024-02-29 | Acquired 100% of M&F Management and Financing GmbH (TCS) for $34.9 million. |
| 2024-08-07 | Entered into the Amended and Restated Credit Agreement (2024 Credit Agreement), replacing the 2021 Credit Agreement. |
| 2024-11-25 | Received an adverse jury verdict in the Oxygenator Water Techs, Inc. intellectual property damages dispute. |
| 2024-12-31 | Adopted ASU 2023-07, Improvements to Reportable Segment Disclosures; End of fiscal year 2024. |
| 2025-01-01 | Certain provisions of the U.S. H.R. 1 'One Big Beautiful Bill Act' became effective. |
| 2025-02-11 | Board of Directors authorized the repurchase of 2,000,000 shares of common stock. |
| 2025-07-04 | U.S. enacted H.R. 1 'A bill to provide for reconciliation pursuant to Title II of H. Con. Res. 14,' commonly referred to as the One Big Beautiful Bill Act. |
| 2025-09-01 | Acquired 100% of Reinigungstechnik 4 You GmbH (R4Y) for $3.6 million. |
| 2025-09-17 | Court issued a post-trial ruling enhancing damages by 30% in the Oxygenator Water Techs, Inc. lawsuit. |
| 2025-09-30 | End of the quarterly period covered by this report. |
| 2025-10-31 | Number of common stock shares outstanding. |
| 2025-11-04 | Filing date of the Form 10-Q. |
| 2026-04-03 | Maturity date of the 2021 Credit Agreement. |
| 2026-12-01 | Maturity date of the interest rate swaps. |
| 2026-12-15 | ASU 2024-03 effective for annual periods beginning after this date. |
| 2027-04-01 | Scheduled maturity and principal payment of the intercompany loan and related cross-currency swaps. |
| 2027-06-30 | ASU 2023-06 effective for the company no later than this date. |
| 2027-12-15 | ASU 2024-03 effective for interim periods within fiscal years beginning after this date. |
| 2029-08-07 | Maturity date of the 2024 Credit Agreement. |
Recommendation
holdThe company's Q3 and YTD 2025 financial results show a clear deterioration in key metrics like net sales, net income, and EPS, indicating significant operational headwinds. While the company is actively pursuing strategic initiatives such as acquisitions, restructuring, and ERP system implementation, and has a strong liquidity position with ample unused borrowing capacity, the immediate financial impact is negative. The substantial increase in legal liabilities from the OWT lawsuit adds to the financial burden. Given the mixed performance, ongoing macroeconomic uncertainties, and the time required for strategic initiatives to yield positive results, a 'hold' recommendation is appropriate. Investors should monitor the effectiveness of cost control and pricing strategies, the resolution of legal matters, and the impact of global economic conditions on future performance before making further investment decisions.
Keywords
Industrial Cleaning Equipment, Floor Maintenance, Cleaning Technologies, Aftermarket Parts, Equipment Service, Asset Management, SEC Filing, Quarterly Report, Financial Results, Net Sales, Net Income, EPS, Gross Margin, Operating Income, Restructuring, Acquisitions, Legal Proceedings, Debt, Share Repurchase, Macroeconomic, Foreign Currency, Supply Chain, Tariffs, ERP System
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.